SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-022672
Filing Date
2016-08-04
Accepted
2016-08-04 16:02:10
Documents
44
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ceru-10q_20160630.htm 10-Q 1550813
2 EX-10.1 ceru-ex101_107.htm EX-10.1 16469
3 EX-10.2 ceru-ex102_108.htm EX-10.2 39983
4 EX-31.1 ceru-ex311_9.htm EX-31.1 15104
5 EX-31.2 ceru-ex312_8.htm EX-31.2 15062
6 EX-32.1 ceru-ex321_7.htm EX-32.1 4460
7 EX-32.2 ceru-ex322_6.htm EX-32.2 4413
8 GRAPHIC g3gvtaqatu5i000001.jpg GRAPHIC 2744
  Complete submission text file 0001564590-16-022672.txt   3731791

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ceru-20160630.xml EX-101.INS 552210
10 XBRL TAXONOMY EXTENSION SCHEMA ceru-20160630.xsd EX-101.SCH 22679
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ceru-20160630_cal.xml EX-101.CAL 26691
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ceru-20160630_def.xml EX-101.DEF 66813
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ceru-20160630_lab.xml EX-101.LAB 216251
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ceru-20160630_pre.xml EX-101.PRE 155637
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 161807299
SIC: 2834 Pharmaceutical Preparations